Andrew B Glasnapp

Title: Innovations by Andrew B Glasnapp

Introduction

Andrew B Glasnapp is an accomplished inventor based in Sugar Land, Texas. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating infectious diseases and inflammatory conditions. With a total of three patents to his name, Glasnapp's work showcases his dedication to advancing medical treatments.

Latest Patents

Glasnapp's latest patents include an antibiotic composition that comprises a chemotactic agent and a nutrient dispersion. This innovative composition is designed to treat infectious diseases caused by biofilms, which are clusters of bacteria that can be resistant to standard treatments. The pharmaceutical composition may include various active ingredients, such as ciprofloxacin and amikacin, along with a nutrient dispersion that enhances the effectiveness of the antibiotics.

Another notable patent is a piroxicam transdermal composition aimed at treating plantar fasciitis. This transdermal method combines piroxicam with a natural permeation enhancement composition to improve skin permeability. This approach allows for a more effective and faster treatment of pain associated with plantar fasciitis, demonstrating Glasnapp's commitment to improving patient care.

Career Highlights

Andrew B Glasnapp is associated with Professional Compounding Centers of America (PCCA), where he applies his expertise in pharmaceutical innovations. His work at PCCA has allowed him to collaborate with other professionals in the field, further enhancing the development of effective medical treatments.

Conclusion

Andrew B Glasnapp's contributions to pharmaceutical innovations reflect his commitment to improving healthcare solutions. His patents demonstrate a focus on addressing complex medical challenges, particularly in the treatment of infections and inflammatory conditions. Through his work, Glasnapp continues to make a significant impact in the field of medicine.